These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 1988578)

  • 21. Interferon instillation for malignant pleural effusions.
    Goldman CA; Skinnider LF; Maksymiuk AW
    Ann Oncol; 1993 Feb; 4(2):141-5. PubMed ID: 8448082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical observation on the efficacy of Xiaoshui decoction combined with intrapleural perfusion of cisplatin in treating malignant pleural effusion.
    SHI Z; HE QY; HUA BJ
    Chin J Integr Med; 2008 Dec; 14(4):257-61. PubMed ID: 19082796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intrapleural DDP and systemic thiosulfate rescue in the treatment of malignant pleural effusion].
    Hua X; Lu W; Duan G
    Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):50-2. PubMed ID: 7656790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesothelioma: a phase II FONICAP trial. Italian Lung Cancer Task Force.
    Pennucci MC; Ardizzoni A; Pronzato P; Fioretti M; Lanfranco C; Verna A; Giorgi G; Vigani A; Frola C; Rosso R
    Cancer; 1997 May; 79(10):1897-902. PubMed ID: 9149015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions.
    Perng RP; Chen YM; Wu MF; Chou KC; Lin WC; Liu JM; Whang-Peng J
    Respir Med; 1998 Mar; 92(3):473-9. PubMed ID: 9692108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of failure following surgical resection for malignant pleural mesothelioma.
    Jänne PA; Baldini EH
    Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrapleural perfusion hyperthermo-chemotherapy for malignant pleural dissemination and effusion.
    Matsuzaki Y; Shibata K; Yoshioka M; Inoue M; Sekiya R; Onitsuka T; Iwamoto I; Koga Y
    Ann Thorac Surg; 1995 Jan; 59(1):127-31. PubMed ID: 7818311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrapleural urokinase for the treatment of loculated malignant pleural effusions and trapped lungs in medically inoperable cancer patients.
    Hsu LH; Soong TC; Feng AC; Liu MC
    J Thorac Oncol; 2006 Jun; 1(5):460-7. PubMed ID: 17409900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
    Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G
    In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal management of malignant mesothelioma after subtotal pleurectomy: revisiting the role of intrapleural chemotherapy and postoperative radiation.
    Sauter ER; Langer C; Coia LR; Goldberg M; Keller SM
    J Surg Oncol; 1995 Oct; 60(2):100-5. PubMed ID: 7564374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion.
    Kitamura K; Kubota K; Ando M; Takahashi S; Nishijima N; Sugano T; Toyokawa M; Miwa K; Kosaihira S; Noro R; Minegishi Y; Seike M; Yoshimura A; Gemma A
    Cancer Chemother Pharmacol; 2013 Feb; 71(2):457-61. PubMed ID: 23178954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High doses of intrapleural cisplatin in a case of malignant pleural mesothelioma. Clinical observations and pharmacokinetic analyses.
    Lerza R; Esposito M; Vannozzi M; Bottino GB; Bogliolo G; Pannacciulli I
    Cancer; 1994 Jan; 73(1):79-84. PubMed ID: 8275441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of remission in diffuse pleural mesothelioma induced by anticancer chemotherapy with cisplatin and adriamycin].
    Kinoshita S; Yamashita T; Yagi M; Bando H; Tsubura E; Sano T
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1872-6. PubMed ID: 4041164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intrapleural bleomycin for management of malignant pleural effusions].
    Sugita T; Matsunaga K; Kobayashi H; Horikawa S; Suzuki Y; Nishiyama H; Maekawa N; Furuta H; Inui H; Fujimoto H
    Gan To Kagaku Ryoho; 1995 Aug; 22(9):1203-7. PubMed ID: 7544964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carboplatin and cisplatin pharmacokinetics after intrapleural combination treatment in patients with malignant pleural effusion.
    Lerza R; Vannozzi MO; Tolino G; Viale M; Bottino GB; Bogliolo G; Cerruti A; Castello G; Mencoboni M; Reggiardo G; Pannacciulli I; Esposito M
    Ann Oncol; 1997 Apr; 8(4):385-91. PubMed ID: 9209670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intrathoracic infusion with a combination of low-dose minocycline, OK-432 and cisplatin for malignant pleural effusion].
    Ishimori S; Okada S; Yamagata S; Satoh S
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):345-9. PubMed ID: 15791817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective randomized trial of intrapleural bleomycin versus interferon alfa-2b via ultrasound-guided small-bore chest tube in the palliative treatment of malignant pleural effusions.
    Sartori S; Tassinari D; Ceccotti P; Tombesi P; Nielsen I; Trevisani L; Abbasciano V
    J Clin Oncol; 2004 Apr; 22(7):1228-33. PubMed ID: 15051770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study of repeated intrapleural chemotherapy using implantable access system for management of malignant pleural effusion.
    Shoji T; Tanaka F; Yanagihara K; Inui K; Wada H
    Chest; 2002 Mar; 121(3):821-4. PubMed ID: 11888966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined intrapleural and intravenous chemotherapy, and pulmonary irradiation, for treatment of patients with lung cancer presenting with malignant pleural effusion. A pilot study.
    Su WC; Lai WW; Chen HH; Hsiue TR; Chen CW; Huang WT; Chen TY; Tsao CJ; Wang NS
    Oncology; 2003; 64(1):18-24. PubMed ID: 12457027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma.
    Lu C; Perez-Soler R; Piperdi B; Walsh GL; Swisher SG; Smythe WR; Shin HJ; Ro JY; Feng L; Truong M; Yalamanchili A; Lopez-Berestein G; Hong WK; Khokhar AR; Shin DM
    J Clin Oncol; 2005 May; 23(15):3495-501. PubMed ID: 15908659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.